Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9008 |
High Similarity |
NPD422 |
Phase 1 |
0.8661 |
High Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.8644 |
High Similarity |
NPD5535 |
Approved |
0.8561 |
High Similarity |
NPD3748 |
Approved |
0.8527 |
High Similarity |
NPD1296 |
Phase 2 |
0.8527 |
High Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8525 |
High Similarity |
NPD1548 |
Phase 1 |
0.8473 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8473 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.8425 |
Intermediate Similarity |
NPD3267 |
Approved |
0.8425 |
Intermediate Similarity |
NPD3266 |
Approved |
0.8346 |
Intermediate Similarity |
NPD3225 |
Approved |
0.8281 |
Intermediate Similarity |
NPD2797 |
Approved |
0.8254 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8248 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8231 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8222 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8205 |
Intermediate Similarity |
NPD9697 |
Approved |
0.8175 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.8106 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8106 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7985 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7955 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7943 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7917 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7914 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7899 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7899 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7887 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7842 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7833 |
Intermediate Similarity |
NPD3134 |
Approved |
0.782 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7808 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7794 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7786 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD920 |
Approved |
0.7769 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7762 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7755 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7754 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7754 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7754 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7746 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7734 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7721 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7721 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7721 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7704 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7703 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7703 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7698 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7674 |
Intermediate Similarity |
NPD17 |
Approved |
0.7655 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7651 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7639 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7639 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.763 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7615 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7609 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7606 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7594 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7589 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7568 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.754 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7538 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7536 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7536 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7533 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7519 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1608 |
Approved |
0.75 |
Intermediate Similarity |
NPD5451 |
Approved |
0.75 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7481 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7481 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7464 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7448 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7448 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7448 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7445 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7434 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7424 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7415 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.74 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7397 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7391 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD919 |
Approved |
0.7376 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7372 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7368 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7361 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7361 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7361 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7353 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7351 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7351 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7347 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.7328 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7324 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7323 |
Intermediate Similarity |
NPD7843 |
Approved |
0.732 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7319 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7313 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7313 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7293 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7287 |
Intermediate Similarity |
NPD2557 |
Approved |
0.7273 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7267 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7266 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7261 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD6666 |
Approved |
0.726 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7259 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7252 |
Intermediate Similarity |
NPD6581 |
Approved |
0.7252 |
Intermediate Similarity |
NPD6580 |
Approved |
0.7239 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7233 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7231 |
Intermediate Similarity |
NPD3596 |
Phase 2 |
0.7214 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7213 |
Intermediate Similarity |
NPD846 |
Approved |
0.7213 |
Intermediate Similarity |
NPD940 |
Approved |
0.7208 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7203 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7203 |
Intermediate Similarity |
NPD6099 |
Approved |
0.72 |
Intermediate Similarity |
NPD290 |
Approved |
0.7197 |
Intermediate Similarity |
NPD6830 |
Clinical (unspecified phase) |
0.7183 |
Intermediate Similarity |
NPD2200 |
Suspended |
0.7183 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7179 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7176 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7164 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7164 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7163 |
Intermediate Similarity |
NPD4622 |
Approved |
0.7163 |
Intermediate Similarity |
NPD4618 |
Approved |
0.7162 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7154 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7153 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7124 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7122 |
Intermediate Similarity |
NPD5163 |
Phase 2 |
0.712 |
Intermediate Similarity |
NPD968 |
Approved |
0.7115 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7111 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7095 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7083 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7083 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7071 |
Intermediate Similarity |
NPD3374 |
Clinical (unspecified phase) |
0.7071 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7068 |
Intermediate Similarity |
NPD3443 |
Approved |
0.7068 |
Intermediate Similarity |
NPD3445 |
Approved |
0.7068 |
Intermediate Similarity |
NPD3049 |
Approved |
0.7068 |
Intermediate Similarity |
NPD3444 |
Approved |
0.7063 |
Intermediate Similarity |
NPD5689 |
Approved |
0.7063 |
Intermediate Similarity |
NPD5688 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD4359 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7055 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.705 |
Intermediate Similarity |
NPD2614 |
Approved |
0.7044 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7034 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7034 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7034 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7034 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7034 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7032 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7029 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7023 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7023 |
Intermediate Similarity |
NPD6387 |
Discontinued |
0.7019 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7007 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7007 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7007 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.6992 |
Remote Similarity |
NPD9545 |
Approved |
0.6986 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6978
|
Remote Similarity |
NPD2237 |
Approved |